Drawing for LIFECYCLE PHARMA

USPTO serial 78250680

LIFECYCLE PHARMA

Reviewed by CopyMark Law Group

Reg. 3520603Status 710
Filing date
Status date
Registration date
Oct 21, 2008
Examiner
EDWARDS, ALICIA COLLINS
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with LIFECYCLE PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bassam N. Ibrahim

Bassam N. Ibrahim Buchanan Ingersoll & Rooney PCP.O. Box 1404Alexandria, VA 22313-1404UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations; medical preparations; and drug delivery systems, pharmaceutical modified release systems, and controlled release systems, comprised of tablets, granules, pills, sachets, powders, and capsules; all of the above for use in the treatment of mental and physical disorders, traumas and emergencies, addictions, aging, allergy/immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical- and gynecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions in the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions and generalised painSECTION 8 - CANCELLED—
040Treatment of materials, namely, milling, grinding, mixing, compressing, and melting of pharmaceutical, medicinal, biotechnical and bacteriological substances, preparations, formulations, solutions, for use in the pharmaceutical and medical industriesSECTION 8 - CANCELLED—
041Educational training services, namely, arranging and conducting of seminars, workshops, conferences, lectures and congresses, all in the medical, chemical and pharmaceutical fieldsSECTION 8 - CANCELLED—
042Scientific research within the medical, pharmaceutical, biotechnical and bacteriological areas and providing consultation and information relating thereto; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; preparation of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; and materials testing for the pharmaceutical and medical industries.SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 22, 2015C8..CANCELLED SEC. 8 (6-YR)—
Nov 23, 2011ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 21, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 5, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 16, 2008NPUBNOTICE OF PUBLICATION—
Jun 3, 2008ADBS1(B) BASIS DELETED; NEW BASIS REQUESTED—
Jun 2, 2008PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
May 29, 2008APETASSIGNED TO PETITION STAFF—
May 23, 2008IUCNNOTICE OF ALLOWANCE CANCELLED—
May 23, 2008PDCBPETITION TO DIRECTOR - CHANGE BASIS - RECEIVED—
May 23, 2008MAILPAPER RECEIVED—
Nov 20, 2007EX5GSOU EXTENSION 5 GRANTED—
Nov 20, 2007EXT5SOU EXTENSION 5 FILED—
Nov 20, 2007EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 20, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 20, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 16, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 16, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 10, 2007EX4GSOU EXTENSION 4 GRANTED—
Apr 3, 2007EXT4SOU EXTENSION 4 FILED—
Apr 3, 2007EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 22, 2006EX3GSOU EXTENSION 3 GRANTED—
Nov 8, 2006EXT3SOU EXTENSION 3 FILED—
Nov 8, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 21, 2006EX2GSOU EXTENSION 2 GRANTED—
Apr 21, 2006EXT2SOU EXTENSION 2 FILED—
Apr 21, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 9, 2005EX1GSOU EXTENSION 1 GRANTED—
Nov 9, 2005EXT1SOU EXTENSION 1 FILED—
Nov 9, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 24, 2005NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 1, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 9, 2005NPUBNOTICE OF PUBLICATION—
Dec 29, 2004MAILPAPER RECEIVED—
Dec 23, 2004PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 22, 2004ALIEASSIGNED TO LIE—
Nov 17, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 29, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Aug 25, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 25, 2004TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 20, 2004GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 19, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 19, 2004MAILPAPER RECEIVED—
Feb 17, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 20, 2003GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 20, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance